These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17804962)

  • 1. Are women with polycystic ovary syndrome (PCOS) at higher risk for development of Alzheimer disease?
    Sabayan B; Foroughinia F; Borhani Haghighi A; Mowla A
    Alzheimer Dis Assoc Disord; 2007; 21(3):265. PubMed ID: 17804962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polycystic ovary syndrome: a disorder of insulin action and an increased risk for onset of non-insulin-dependent diabetes].
    Aganović I; Jelcić J; Kozić-Rukavina B
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():28-32. PubMed ID: 8759405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome.
    Meyer C; Talbot M; Teede H
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):155-8. PubMed ID: 15760320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome.
    Vervita V; Saltamavros AD; Adonakis G; Tsapanos V; Decavalas G; Georgopoulos NA
    Gynecol Endocrinol; 2009 Oct; 25(10):640-6. PubMed ID: 19557593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal disease in polycystic ovary syndrome.
    Dursun E; Akalın FA; Güncü GN; Çınar N; Aksoy DY; Tözüm TF; Kılınc K; Yıldız BO
    Fertil Steril; 2011 Jan; 95(1):320-3. PubMed ID: 20800834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
    Amador N; Espinoza G; Guízar JM; González M; Alpízar M
    Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
    Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
    Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K; Child T
    J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.